JP2013544272A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013544272A5 JP2013544272A5 JP2013541414A JP2013541414A JP2013544272A5 JP 2013544272 A5 JP2013544272 A5 JP 2013544272A5 JP 2013541414 A JP2013541414 A JP 2013541414A JP 2013541414 A JP2013541414 A JP 2013541414A JP 2013544272 A5 JP2013544272 A5 JP 2013544272A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- mtc
- diluent
- direct compression
- compressed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41816410P | 2010-11-30 | 2010-11-30 | |
| US61/418,164 | 2010-11-30 | ||
| PCT/GB2011/001662 WO2012072977A2 (en) | 2010-11-30 | 2011-11-30 | Compound formulations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013544272A JP2013544272A (ja) | 2013-12-12 |
| JP2013544272A5 true JP2013544272A5 (enExample) | 2016-06-16 |
| JP6093707B2 JP6093707B2 (ja) | 2017-03-08 |
Family
ID=45418703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013541414A Active JP6093707B2 (ja) | 2010-11-30 | 2011-11-30 | 化合物製剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9192611B2 (enExample) |
| EP (1) | EP2645994B1 (enExample) |
| JP (1) | JP6093707B2 (enExample) |
| CN (1) | CN103379901B (enExample) |
| AU (1) | AU2011334679B2 (enExample) |
| CA (1) | CA2818068C (enExample) |
| ES (1) | ES2655492T3 (enExample) |
| MY (1) | MY163074A (enExample) |
| SG (2) | SG10201602111VA (enExample) |
| WO (1) | WO2012072977A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014153444A (ja) * | 2013-02-06 | 2014-08-25 | Konica Minolta Inc | 位相差フィルム、偏光板及び液晶表示装置 |
| AU2017301966B2 (en) | 2016-07-25 | 2022-09-22 | TauRx Therapeutics Management Ltd | Administration and dosage of diaminophenothiazines |
| FR3104438B1 (fr) * | 2019-12-12 | 2021-11-19 | Univ Bordeaux | Formulation pour le bleu de methylene et procede |
| EP4531863A1 (en) | 2022-05-31 | 2025-04-09 | WisTa Laboratories Ltd. | Treatment of neurodegenerative disorders utilising methylthioninium (mt)-containing compounds |
| EP4590306A1 (en) | 2022-09-21 | 2025-07-30 | Yin Sze Loh | Oral formulation of diaminophenothiazines and methods of making and using the same in the treatment and/or prevention of diseases |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4880373A (en) | 1988-04-28 | 1989-11-14 | The Upjohn Company | Tablet press |
| JPH0840942A (ja) * | 1994-07-29 | 1996-02-13 | Kanegafuchi Chem Ind Co Ltd | 薬物放出制御製剤 |
| GB9506197D0 (en) | 1995-03-27 | 1995-05-17 | Hoffmann La Roche | Inhibition of tau-tau association. |
| GB0101049D0 (en) | 2001-01-15 | 2001-02-28 | Univ Aberdeen | Materials and methods relating to protein aggregation in neurodegenerative disease |
| GB0106953D0 (en) | 2001-03-20 | 2001-05-09 | Univ Aberdeen | Neufofibrillary labels |
| GB0322756D0 (en) | 2003-09-29 | 2003-10-29 | Univ Aberdeen | Methods of chemical synthesis |
| PT1799662E (pt) | 2004-09-23 | 2013-07-09 | Wista Lab Ltd | Métodos de síntese química e purificação de compostos de diaminofenotiazínio incluindo cloreto de metiltionínio (mtc) |
| US7790881B2 (en) * | 2004-09-23 | 2010-09-07 | Wista Laboratories Ltd. | Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (MTC) |
| EP2283811A1 (en) * | 2004-10-19 | 2011-02-16 | Krka Tovarna Zdravil, D.D., Novo Mesto | Solid pharmaceutical composition comprising donepezil hydrochloride |
| EP1919456A2 (en) * | 2005-08-24 | 2008-05-14 | Wyeth a Corporation of the State of Delaware | Bazedoxifene acetate formulations and manufacturing process thereof |
| EP1808165B1 (en) * | 2006-01-05 | 2009-04-29 | Teva Pharmaceutical Industries Ltd | Dry formulations of aripiprazole |
| CN109384741B (zh) | 2006-03-29 | 2023-01-06 | 维斯塔实验室有限公司 | 3,7-二氨基-10h-吩噻嗪化合物盐及其用途 |
| US20080317678A1 (en) * | 2007-06-22 | 2008-12-25 | Szymczak Christopher E | Laser Marked Dosage Forms |
| SI2205245T1 (sl) | 2007-10-03 | 2015-10-30 | Wista Laboratories Ltd. | Terapevtska uporaba diaminofenotiazinov |
| CN101911081A (zh) | 2007-11-05 | 2010-12-08 | 维斯塔实验室有限公司 | 用于临床试验的体系 |
| PL2480540T3 (pl) * | 2009-09-24 | 2018-05-30 | Wista Laboratories Ltd. | Pentahydrat chlorku metylotioninowego, jego wytwarzanie i zastosowanie farmaceutyczne |
-
2011
- 2011-11-30 US US13/989,953 patent/US9192611B2/en active Active
- 2011-11-30 CA CA2818068A patent/CA2818068C/en active Active
- 2011-11-30 JP JP2013541414A patent/JP6093707B2/ja active Active
- 2011-11-30 AU AU2011334679A patent/AU2011334679B2/en active Active
- 2011-11-30 ES ES11802119.5T patent/ES2655492T3/es active Active
- 2011-11-30 CN CN201180057700.9A patent/CN103379901B/zh active Active
- 2011-11-30 MY MYPI2013001934A patent/MY163074A/en unknown
- 2011-11-30 EP EP11802119.5A patent/EP2645994B1/en active Active
- 2011-11-30 WO PCT/GB2011/001662 patent/WO2012072977A2/en not_active Ceased
- 2011-11-30 SG SG10201602111VA patent/SG10201602111VA/en unknown
- 2011-11-30 SG SG2013040357A patent/SG190406A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2015215000B2 (en) | Solid pharmaceutical compositions of androgen receptor antagonists | |
| EP2068839B1 (en) | Pharmaceutical compositions comprising nilotinib or its salt | |
| TWI700100B (zh) | 用於口服投藥之包含依澤替米貝（ｅｚｅｔｉｍｉｂｅ）及羅舒伐他汀（ｒｏｓｕｖａｓｔａｔｉｎ）的複合調配物及其製備方法 | |
| KR20150067153A (ko) | 티카그렐러를 함유하는 고형의 경구용 약학 제제 | |
| CN101951889A (zh) | 伊马替尼组合物 | |
| EP2051694A2 (en) | Pharmaceutical compositions comprising aripiprazole | |
| WO2008134013A2 (en) | Pharmaceutical excipient complex | |
| JP2013544272A5 (enExample) | ||
| TWI774159B (zh) | 含有托格列淨（Tofogliflozin）之固體製劑及其製造方法 | |
| KR101230178B1 (ko) | 골다공증 예방 또는 치료용 조성물 및 이의 제조방법 | |
| JP5415561B2 (ja) | Ｈｃｖポリメラーゼ阻害剤のプロドラッグを含む医薬組成物 | |
| JP2017523149A (ja) | エドキサバンの医薬組成物 | |
| CN108174596A (zh) | 包含8-[(3r)-3-氨基-1-哌啶基]-7-(2-丁炔-1-基)-3,7-二氢-3-甲基-1-[4-甲基-2-喹唑啉基)甲基]-1h-嘌呤-2,6-二酮或其药学上可接受的盐的药物组合物 | |
| WO2015022559A1 (en) | Pharmaceutical composition containing rosuvastatin and ramipril | |
| EP2946771B1 (en) | Water-dispersible tablet formulation comprising deferasirox | |
| JP5755382B2 (ja) | 口腔内崩壊錠 | |
| CN102423482B (zh) | 复方氨氯地平赖诺普利片的制备方法 | |
| JP7233852B2 (ja) | 変色が抑制された固形製剤 | |
| WO2015199115A1 (ja) | 経口投与用医薬組成物 | |
| EP4279075B1 (en) | A pharmaceutical composition comprising elagolix | |
| JP6272328B2 (ja) | カンデサルタンシレキセチル含有製剤 | |
| GR1009619B (el) | Φαρμακευτικη συνθεση που περιεχει ριβαροξαβανη και μεθοδος για την παρασκευη αυτης | |
| RU2261094C1 (ru) | Твердая лекарственная форма для лечения артериальной гипертензии и способ ее изготовления | |
| WO2014002851A1 (ja) | 固形医薬錠剤およびその製造方法 | |
| JP2013103924A (ja) | 結晶性アトルバスタチンカルシウム含有錠剤の製造方法 |